100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Translational Neuroscience (MED-MIN16 ) Clinical Research & Treatment summary $5.55   Add to cart

Summary

Translational Neuroscience (MED-MIN16 ) Clinical Research & Treatment summary

 23 views  1 purchase
  • Course
  • Institution

Translational Neuroscience (MED-MIN16 ) Clinical Research & Treatment summary of all lectures. Great for people who struggle with big chunks of text. Lots of pictures and bullet points.

Preview 2 out of 9  pages

  • September 24, 2022
  • 9
  • 2020/2021
  • Summary
avatar-seller
Clinical Research & Treatment
Alzheimer’s Disease
Cholinesterase-inhibitors (ChEIs) are a group of medicines that block the normal breakdown of
acetylcholine. Acetylcholine is the main neurotransmitter found in the body and has functions in
both the peripheral nervous system and the central nervous system.
• Reduce synaptic breakdown of the neurotransmitter acetylcholine
• Targets the intrinsic cholinergic system in the brain
• Improvements in attention, memory.

Amyloid cascade hypothesis
The amyloid cascade hypothesis posits that the deposition of the amyloid-β peptide in the brain
parenchyma is a crucial step that ultimately leads to Alzheimer's disease.




The amyloid accumulation starts very early and is asymptomatic. It’s the hyper-phosphorylation of
tau that causes the neurodegeneration and leads to symptoms. Not the amyloid on its own but in
combination with tau toxicity.

Recent research and treatment
Treatment aimed at amyloid toxicity
• Goal: removing / reducing amyloid
• To reduce synaptic toxicity
• What has been studied?
o Immune therapy (vaccination /antibodies against amyloid-beta)
o Targeting enzymes (BACE, gamma-secretase) that ‘produce’ amyloid-beta

Pitfalls of anti-amyloid treatment
• Too little, too late:
• Little: Synaptic toxicity: not only amyloid, but also tau, inflammation, …
• Late; Widespread synaptic breakdown is irreversible
• Other pathology (tau, inflammation) may continue, even if amyloid is removed

, Amyloid plaque reduction with aducanumab has been affective
but the cognitive effects of this treatment was really small.

Other treatment options




Reducing the risk factors for Alzheimer’s
is an important part of the options.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller romykiffen. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $5.55. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75759 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you


$5.55  1x  sold
  • (0)
  Add to cart